Andrew Booth insider trades

Open-market stock purchases and sales by Andrew Booth, Chief Financial Officer at AbCellera Biologics Inc, from SEC Form 4 filings since Jun 7, 2021.

Track record: 67% of 6 scored buys are up 5% or more since purchase, averaging +63%.

Recent trades

DateStockTradeValue
Aug 14, 2026ABCL AbCellera Biologics IncBought$384K
Jun 3, 2026ABCL AbCellera Biologics IncBought (not open market)—
Feb 27, 2026ABCL AbCellera Biologics IncBought$146K
Jan 1, 2026ABCL AbCellera Biologics IncBought (not open market)—

Companies traded

  • ABCL AbCellera Biologics Inc: 6 buys, 1 sale, last Aug 14, 2026

Get free alerts when Andrew Booth files a new trade →